Home » Topics » Disease categories and therapies » Infection

Infection
RSS

FDA decides to continue review of Relenza NDA

April 8, 1999

Production and activity of new antimicrobial compound described by Teijin

April 8, 1999

Novel antibiotic active against acid-fast bacteria presented at recent Japanese congress

April 7, 1999

New carbapenems synthesized at Merck useful against resistant staphylococci

April 7, 1999

International team identifies myristic acid analogues with antipicornaviral activity

March 31, 1999

In vitro and in vivo profile of SB-265805 discussed at European microbiology meeting

March 31, 1999

Emoxipin analogues studied by Russian team in animal models of infection

March 31, 1999

Kyorin describes production, synthesis and structure of novel antibacterial substance

March 31, 1999

Liposomal antiseptic enters clinical testing at Mundipharma

March 31, 1999

Australian authorities approve Relenza for treatment of influenza

March 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...